1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. Diamyd Medical AB Acquires Nurel Therapeutics

M&A Deal Summary

Diamyd Medical AB Acquires Nurel Therapeutics

On November 22, 2005, Diamyd Medical AB acquired life science company Nurel Therapeutics

Acquisition Highlights
  • This is Diamyd Medical AB’s 1st transaction in the Life Science sector.
  • This is Diamyd Medical AB’s 1st transaction in the United States.
  • This is Diamyd Medical AB’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2005-11-22
Target Nurel Therapeutics
Sector Life Science
Buyer(s) Diamyd Medical AB
Deal Type Add-on Acquisition

Target

Nurel Therapeutics

Pittsburgh, Pennsylvania, United States
Nurel Therapeutics, Inc. is a specialty biotechnology company that is developing unique products to treat and manage pain and peripheral nerve damage.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Diamyd Medical AB

Stockholm, Sweden
Category Company
Sector Medical Products
Employees7
DESCRIPTION

Diamyd Medical AB is a provider of medical products in sweden.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2005 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal